Andean Precious Metals Corp. (CVE:APM – Get Free Report) was up 7.5% on Friday . The company traded as high as C$1.29 and last traded at C$1.29. Approximately 225,691 shares changed hands during mid-day trading, an increase of 41% from the average daily volume of 159,585 shares. The stock had previously closed at C$1.20.
Analyst Upgrades and Downgrades
Separately, Desjardins reduced their target price on Andean Precious Metals from C$2.10 to C$2.00 and set a “buy” rating for the company in a report on Thursday, March 20th.
Check Out Our Latest Stock Analysis on APM
Andean Precious Metals Price Performance
Andean Precious Metals Company Profile
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.
See Also
- Five stocks we like better than Andean Precious Metals
- Top Stocks Investing in 5G Technology
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
- Why Are Stock Sectors Important to Successful Investing?
- Overheated Market? Analysts Watch These Red Flags
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Reasons AMD Could Be the Hottest Stock of the Summer
Receive News & Ratings for Andean Precious Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andean Precious Metals and related companies with MarketBeat.com's FREE daily email newsletter.